The emerging evidence on the role of SMURF2 in modulating ferroptosis by mediating the degradation of glutathione S-transferase P1 (GSTP1) dismantles a key defense against ferroptosis, thereby predisposing cancer cells to this unique form of cell death (103, 127). The gene discussed is GSTP1; the disease is cancer.